Dr. Harald Mikkers of Leiden University Medical Center in the Netherlands will work to advance and improve a state-of-the-art personalized medicine tool for GNAO1. He will use funding from the Bow Foundation to create a validated stem cell GNAO1 model that opens the doors to various drug screening efforts. The work will investigate how GNAO1 impacts neurons and evaluate the suitability of the iPSC-based model for testing of therapeutics and drug responses.
Harald Mikkers of Leiden University Medical Center supported by Bow Foundation to create a validated stem cell GNAO1 model
$100,000 to further iSPC research and advance patient-specific treatments
